Product Images Wynzora
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Wynzora NDC 73499-001 by Mc2 Therapeutics Ltd, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - wynzora 01
Chemical Structure - wynzora 02
PRINCIPAL DISPLAY PANEL - 60 g Tube Carton - wynzora 03
Wynzora is a cream medication for topical use only, containing calcipotriene and betamethasone dipropionate. It is meant to be applied once a day to affected areas or as directed by a physician. Each gram of cream contains 50 mg of calcipotriene and 0.4 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone). The cream also contains various inactive ingredients. The storage temperature should be kept between 20°C-75°C (68°F-86°F), and the medication should not be frozen. The cream is distributed by EP Health, LLC and manufactured for MC2 Therapeutics in the United States and the United Kingdom. No other information on its use or indications is given.*
wynzora 04
This is a description of a cream named "AVYAViaV4" which is for topical use only. It contains "calipotriene and betamethasone dipropionate". The cream is manufactured by Epihealth for MC2 Therapeutics. The cream comes in a tube containing 30 milligrams of cliprionssnd and 0.44 milligrams of a certain substance. The NDC number for the drug is 7349900108.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.